Skip to main content

Table 4 Proportion of clinical characteristics

From: Partner HIV serostatus disclosure and determinants of serodiscordance among prevention of mother to child transmission clients in Nigeria

Variables Total Seroconcordant Serodiscordant Chi-square (p-value) Symetric measures
n % n % n %   Cramer’s V Phi coefficient
Baseline CD4+ count        0.143 (0.706)   0.04
CD4 < 350 40 100 22 55.0 18 45.0    
CD4 > 350 76 100 39 51.3 37 48.7    
WHO clinical staging        8.751 (0.003)*   −0.15
Asymptomatic 373 100 178 47.7 195 52.3    
Symptomatic 15 100 13 86.7 2 13.3    
  1. *Significant (P-value < 0.05)